Title: Bagal SK, et al. Recent progress in sodium channel modulators for pain. Bioorg Med Chem Lett. 2014 Aug 15;24(16):3690-9.
70243-51-5 | (1R,3r,5S)-9-benzyl-9-azabicyclo[3.3.1]nonan-3-ol | AA01DKDL | MFCD00209918
2204040-43-5 | tert-butyl 4-((5-chloropyridin-2-yl)methyl)piperazine-1-carboxylate | AA01FLCD | MFCD31731545
1173836-08-2 | (R)-(+)-4-[2-(Diphenylphosphino)-1-naphthalenyl]-N-[(S)-1-phenylethyl]-1-phthalazinamine, min. 97% (S,R)-N-PINAP | AA01FU1O | MFCD11846210
1253522-03-0 | 2,3-Dichloro-6-(trifluoromethoxy)quinoxaline | AA000NFS | MFCD09842521
122676-92-0 | Cis-2-iodocyclopropanecarboxylic acid | AA0017J0 | MFCD27501034
181950-57-2 | 4-Chloro-7-hydroxyquinoline | AA002359 | MFCD09261120
286836-29-1 | 4-Bromo-5-fluoro-benzofuran | AA002VZF | MFCD23705162
543-75-9 | 1,4-DIOXENE | AA003DM9 | MFCD00082537
3493-37-6 | Imidodicarbonimidic diamide, N-(2-phenylethyl)-, hydrochloride (1:2) | AA005B0Q | MFCD00035039
221222-49-7 | 3,6,9,12,15,18,21-Heptaoxadotriacontanoicacid, 32-mercapto- | AA007025 | MFCD03425590